Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

ClinicalTrials.gov ID: NCT06052267

Public ClinicalTrials.gov record NCT06052267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 5:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic module multidose dry powder inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs). Secondary Objectives: To evaluate the efficacy of Fp/ABS low dose compared to ABS and the effect on systemic corticosteroid (SCS) exposure To evaluate the safety and tolerability of Fp/A BS The duration for each participant will be a minimum of 28 weeks including 2 weeks of screening, 2-4 weeks of run-in period and a double blind treatment period of minimum 24 weeks, however due to the event-driven nature of this study, the duration may range up to approximately 42 months depending on the timing when the participant was enrolled to the study, and when the study reaches its completion criteria

Study identification

NCT ID
NCT06052267
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
2,772 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
4 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2023 (Actual)
Primary completion
Oct 31, 2026 (Estimated)
Completion
Oct 31, 2026 (Estimated)
Last update posted
Oct 14, 2026

2023 – 2026

United States locations

U.S. sites
157
U.S. states
33
U.S. cities
116
Facility City State ZIP Site status
Teva Investigational Site 15706 Birmingham Alabama 35209 —
Teva Investigational Site 15786 Birmingham Alabama 35233 —
Teva Investigational Site 15768 Dothan Alabama 36305 —
Teva Investigational Site 15581 Paradise Valley Arizona 85258 —
Teva Investigational Site 15710 Scottsdale Arizona 85259 —
Teva Investigational Site 15661 Tucson Arizona 85741 —
Teva Investigational Site 15685 Bakersfield California 93301 —
Teva Investigational Site 15721 Fresno California 93704 —
Teva Investigational Site 15788 Huntington Beach California 92647-6853 —
Teva Investigational Site 15720 La Jolla California 92037 —
Teva Investigational Site 15687 La Palma California 90623 —
Teva Investigational Site 15708 Long Beach California 90806-2613 —
Teva Investigational Site 15712 Long Beach California 90815 —
Teva Investigational Site 15643 Los Angeles California 90025 —
Teva Investigational Site 15695 Napa California 94558 —
Teva Investigational Site 15692 Northridge California 91324 —
Teva Investigational Site 15682 Redondo Beach California 90277-5720 —
Teva Investigational Site 15629 San Bernardino California 92408 —
Teva Investigational Site 15709 San Diego California 92120 —
Teva Investigational Site 15704 San Jose California 95117 —
Teva Investigational Site 15620 Stockton California 95207 —
Teva Investigational Site 15621 Westminster California 92683 —
Teva Investigational Site 15612 Aurora Colorado 80014 —
Teva Investigational Site 15588 Colorado Springs Colorado 80907 —
Teva Investigational Site 15765 Colorado Springs Colorado 80922 —
Teva Investigational Site 15676 Englewood Colorado 80110 —
Teva Investigational Site 15781 Washington D.C. District of Columbia 20009 —
Teva Investigational Site 15660 Aventura Florida 33180 —
Teva Investigational Site 15624 Cape Coral Florida 33914 —
Teva Investigational Site 15598 Cutler Bay Florida 33189 —
Teva Investigational Site 15776 Doral Florida 33122 —
Teva Investigational Site 15579 Greenacres City Florida 33476 —
Teva Investigational Site 15582 Hialeah Florida 33012 —
Teva Investigational Site 15664 Hialeah Florida 33012 —
Teva Investigational Site 15657 Homestead Florida 33030 —
Teva Investigational Site 15713 Jacksonville Florida 32207 —
Teva Investigational Site 15632 Leesburg Florida 34748 —
Teva Investigational Site 15777 Margate Florida 33063 —
Teva Investigational Site 15602 Miami Florida 33126 —
Teva Investigational Site 15722 Miami Florida 33126 —
Teva Investigational Site 15724 Miami Florida 33126 —
Teva Investigational Site 15655 Miami Florida 33130 —
Teva Investigational Site 15605 Miami Florida 33142-2946 —
Teva Investigational Site 15634 Miami Florida 33143 —
Teva Investigational Site 15596 Miami Florida 33144 —
Teva Investigational Site 15654 Miami Florida 33144 —
Teva Investigational Site 15773 Miami Florida 33155 —
Teva Investigational Site 15585 Miami Florida 33173 —
Teva Investigational Site 15639 Miami Florida 33173 —
Teva Investigational Site 15645 Miami Florida 33173 —
Teva Investigational Site 15772 Miami Florida 33175 —
Teva Investigational Site 15592 Miami Florida 33176 —
Teva Investigational Site 15769 Miami Florida 33176 —
Teva Investigational Site 15644 Miami Florida 33186 —
Teva Investigational Site 15589 Miami Lakes Florida 33014 —
Teva Investigational Site 15599 Miami Lakes Florida 33014 —
Teva Investigational Site 15595 Miami Lakes Florida 33016 —
Teva Investigational Site 15665 Oldsmar Florida 34677 —
Teva Investigational Site 15659 Orlando Florida 32806 —
Teva Investigational Site 15617 Orlando Florida 32819 —
Teva Investigational Site 15625 Orlando Florida 32825 —
Teva Investigational Site 15597 Pembroke Pines Florida 33025 —
Teva Investigational Site 15767 Sweetwater Florida 33182 —
Teva Investigational Site 15587 Tamarac Florida 33321 —
Teva Investigational Site 15611 Tampa Florida 33604 —
Teva Investigational Site 15619 Tampa Florida 33607-6327 —
Teva Investigational Site 15653 Tampa Florida 33607 —
Teva Investigational Site 15652 Virginia Gardens Florida 33166 —
Teva Investigational Site 15606 Winter Park Florida 32789 —
Teva Investigational Site 15717 Atlanta Georgia 30329 —
Teva Investigational Site 15711 Conyers Georgia 30012 —
Teva Investigational Site 15626 Savannah Georgia 31406-2668 —
Teva Investigational Site 15604 Boise Idaho 83706 —
Teva Investigational Site 15669 Chicago Illinois 60607 —
Teva Investigational Site 15616 Chicago Illinois 60612 —
Teva Investigational Site 15716 Chicago Illinois 60637 —
Teva Investigational Site 15600 Skokie Illinois 60077 —
Teva Investigational Site 15674 Evansville Indiana 47715 —
Teva Investigational Site 15580 Overland Park Kansas 66210 —
Teva Investigational Site 15627 Lexington Kentucky 40509 —
Teva Investigational Site 15770 Lafayette Louisiana 70508 —
Teva Investigational Site 15667 Bangor Maine 04401 —
Teva Investigational Site 15689 Rockville Maryland 20852 —
Teva Investigational Site 15583 White Marsh Maryland 21162 —
Teva Investigational Site 15628 Boston Massachusetts 02115 —
Teva Investigational Site 15686 Fall River Massachusetts 02723 —
Teva Investigational Site 15663 North Dartmouth Massachusetts 02747 —
Teva Investigational Site 15764 South Dartmouth Massachusetts 02747 —
Teva Investigational Site 15702 Detroit Michigan 48202 —
Teva Investigational Site 15701 Flint Michigan 48507 —
Teva Investigational Site 15593 Ypsilanti Michigan 48197 —
Teva Investigational Site 15648 Kansas City Missouri 66160 —
Teva Investigational Site 15640 St Louis Missouri 63110 —
Teva Investigational Site 15650 St Louis Missouri 63123 —
Teva Investigational Site 15633 St Louis Missouri 63141-7068 —
Teva Investigational Site 15790 Hastings Nebraska 68901 —
Teva Investigational Site 15679 Las Vegas Nevada 89123-2875 —
Teva Investigational Site 15725 North Bergen New Jersey 07047 —
Teva Investigational Site 15688 Hawthorne New York 10532 —
Teva Investigational Site 15603 Horseheads New York 14845 —
Teva Investigational Site 15666 Hyde Park New York 11042 —
Teva Investigational Site 15675 New Windsor New York 12553 —
Teva Investigational Site 15618 Asheville North Carolina 28803 —
Teva Investigational Site 15601 Chapel Hill North Carolina 27599 —
Teva Investigational Site 15697 Charlotte North Carolina 28277 —
Teva Investigational Site 15610 Elizabeth City North Carolina 27909-3465 —
Teva Investigational Site 15651 High Point North Carolina 27260 —
Teva Investigational Site 15771 Statesville North Carolina 28625 —
Teva Investigational Site 15631 Wilmington North Carolina 28401 —
Teva Investigational Site 15584 Winston-Salem North Carolina 27157 —
Teva Investigational Site 15607 Cincinnati Ohio 45236 —
Teva Investigational Site 15613 Columbus Ohio 43205 —
Teva Investigational Site 15784 Dayton Ohio 45404 —
Teva Investigational Site 15791 Dayton Ohio 45429 —
Teva Investigational Site 15780 Toledo Ohio 43606 —
Teva Investigational Site 15662 Toledo Ohio 43617 —
Teva Investigational Site 15577 Oklahoma City Oklahoma 73120-9389 —
Teva Investigational Site 15594 Tulsa Oklahoma 74133 —
Teva Investigational Site 15775 Yukon Oklahoma 73099 —
Teva Investigational Site 15646 Grants Pass Oregon 97527 —
Teva Investigational Site 15642 Philadelphia Pennsylvania 19140 —
Teva Investigational Site 15576 Pittsburgh Pennsylvania 15241 —
Teva Investigational Site 15608 North Charleston South Carolina 29420 —
Teva Investigational Site 15672 Rock Hill South Carolina 29732 —
Teva Investigational Site 15691 Knoxville Tennessee 37909 —
Teva Investigational Site 15705 Austin Texas 78759 —
Teva Investigational Site 15641 Boerne Texas 78006 —
Teva Investigational Site 15778 Brownsville Texas 78520 —
Teva Investigational Site 15668 Corsicana Texas 75110 —
Teva Investigational Site 15658 Dallas Texas 75209 —
Teva Investigational Site 15637 Dallas Texas 75231-8206 —
Teva Investigational Site 15623 Dallas Texas 75235 —
Teva Investigational Site 15785 Edinburg Texas 78539 —
Teva Investigational Site 15678 El Paso Texas 79902 —
Teva Investigational Site 15787 El Paso Texas 79902 —
Teva Investigational Site 15591 El Paso Texas 79912 —
Teva Investigational Site 15696 Houston Texas 77008 —
Teva Investigational Site 15714 Houston Texas 77030 —
Teva Investigational Site 15680 Houston Texas 77065 —
Teva Investigational Site 15614 Houston Texas 77074-2005 —
Teva Investigational Site 15578 Houston Texas 77099 —
Teva Investigational Site 15690 Katy Texas 77494 —
Teva Investigational Site 15684 Kerrville Texas 78028 —
Teva Investigational Site 15630 McKinney Texas 75069 —
Teva Investigational Site 15656 San Antonio Texas 78212 —
Teva Investigational Site 15670 San Antonio Texas 78229 —
Teva Investigational Site 15638 San Antonio Texas 78258 —
Teva Investigational Site 15647 Sherman Texas 75090 —
Teva Investigational Site 15673 Splendora Texas 77372 —
Teva Investigational Site 15707 Tomball Texas 77081 —
Teva Investigational Site 15693 Victoria Texas 77901 —
Teva Investigational Site 15649 Waxahachie Texas 75165-1430 —
Teva Investigational Site 15671 Bountiful Utah 84010 —
Teva Investigational Site 15635 Sandy City Utah 84093 —
Teva Investigational Site 15789 West Valley City Utah 84119 —
Teva Investigational Site 15683 Williamsburg Virginia 23188 —
Teva Investigational Site 15586 Greenfield Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 236 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06052267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06052267 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →